Microchip Gel Electrophoretic Analysis of Perchloric Acid-soluble Serum Proteins in Systemic Inflammatory Disorders
Overview
Authors
Affiliations
Perchloric acid (PCA) precipitation is a well-known method for the separation of heavily glycosylated proteins and for reducing the masking effect of major serum proteins. The aim of this study is to characterize PCA-soluble serum proteins in healthy individuals and in patients with systemic inflammatory diseases, such as Crohn's disease and sepsis. A PCA precipitation protocol was prepared and adapted to the analytical methods. After PCA treatment of the serum, the soluble proteins in the supernatant were analyzed by SDS-PAGE and by microchip gel electrophoresis (MGE). Characteristic changes of the electrophoretic patterns of the PCA-soluble fractions were observed. Four characteristic bands (at ∼11, ∼65, ∼85, and ∼120 kDa) with varying intensity were detected by MGE. The proportion of the ∼65, ∼85, and ∼120 kDa bands were significantly higher in systemic inflammatory conditions than in healthy individuals (p < 0.001), and characteristic patterns were observed in patients with acute inflammation. The marked differences in the acid-soluble protein patterns, which were observed in patients with ongoing systemic inflammation, might be a good indicator of inflammation. The MGE analysis is a fast screening and quantification method for the detection of characteristic changes among acid-soluble serum proteins.
Advancements in Adenine Nucleotides Extraction and Quantification from a Single Drop of Human Blood.
Popovic I, Doncevic L, Biba R, Kospic K, Barbalic M, Marinkovic M Molecules. 2024; 29(23).
PMID: 39683788 PMC: 11643363. DOI: 10.3390/molecules29235630.
Varga A, Makszin L, Bufa A, Sipos D, Kasa P, Pal S Front Cell Infect Microbiol. 2023; 13:1041384.
PMID: 36756616 PMC: 9899802. DOI: 10.3389/fcimb.2023.1041384.
Ahmed S, Viode A, van Zalm P, Steen J, Mukerji S, Steen H J Neurovirol. 2022; 28(3):341-354.
PMID: 35639337 PMC: 9945916. DOI: 10.1007/s13365-022-01077-0.
Plasma Proteomic Analysis Distinguishes Severity Outcomes of Human Ebola Virus Disease.
Viode A, Smolen K, Fatou B, Wurie Z, van Zalm P, Konde M mBio. 2022; 13(3):e0056722.
PMID: 35446128 PMC: 9239184. DOI: 10.1128/mbio.00567-22.